# IMBdx, Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/imbdx-co

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.imbdx.com
- Total disclosed funding: $26M
- Latest round: Series B (May 12, 2021)
- Investors on record: 7

## About

Founded in 2018 and based in Seoul, South Korea, IMBdx, Co., Ltd., aka In My Blood Diagnostics, operates as a developer of various medical solutions to diagnose cancer by blood collection using artificial intelligence and big data. Taeyu Kim (co-CEO), Doohee Bang, and Sungtae Moon (co-CEO) are the co-founders of the company. In May 2021, IMBdx Co., Ltd. raised KRW 20.8 billion in series B funding from Samho Green Investment, including Intervest Co., Ltd., BSK Investment, and Partners Investment.

The company specializes in the diagnosis of invisible cancers through its unique liquid biopsy technology. The firm’s core technology, the Alpha Liquid® Platform, enables the detection of various gene mutations in tumour DNA through a single blood sample. IMBDX offers a range of products under the Alpha Liquid® brand, including Alpha Liquid® Profiling, Alpha Liquid® Detect, and Alpha Liquid® Screening. The company provides clinical services in collaboration with major general hospitals in Korea. The firm offers the Alpha Liquid®100 test, which is beneficial for patients who require tumour profiling, treatment matching, response monitoring during chemotherapy, or identification of resistance genes.

## Funding rounds

- Series B, May 12, 2021, $18M — Partners Investment, Samho Green Investment, BSK Investment, Intervest Co., Ltd.
- Series A, Apr 7, 2020, $6.6M — InterVest, Partners Investment, WONIK Investment Partners, BSK Investment
- Seed, Dec 13, 2018, $0.4M — BSK Investment
- Seed, Nov 1, 2018 — Korea Tech Incubator for Startup, BSK Investment

## Investors

- Korea Tech Incubator for Startup — Seed
- BSK Investment (https://capitalatlas.ai/funds/bsk-investment) — Seed, Series A, Series B
- InterVest (https://capitalatlas.ai/funds/intervest) — Series A
- Partners Investment (https://capitalatlas.ai/funds/partners-investment) — Series A, Series B
- WONIK Investment Partners (https://capitalatlas.ai/funds/wonik-investment-partners) — Series A
- Samho Green Investment (https://capitalatlas.ai/funds/samho-green-investment) — Series B
- Intervest Co., Ltd. — Series B